HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Icenticaftor, Novel Therapy for COPD: This Glass Is Half Full.

AuthorsStephen I Rennard
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 208 Issue 4 Pg. 346-348 (08 15 2023) ISSN: 1535-4970 [Electronic] United States
PMID37437299 (Publication Type: Editorial, Comment)
Chemical References
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • icenticaftor
  • CFTR protein, human
Topics
  • Humans
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Double-Blind Method
  • Pulmonary Disease, Chronic Obstructive (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: